At MED Institute, we provide comprehensive pre-clinical testing services that encompass both in-vitro testing and in-vivo biological studies. These are essential methodologies in biomedical research and medical device development, used to evaluate the safety, efficacy, biocompatibility, and biological performance of innovative devices and therapeutics. By integrating both in-vitro and in-vivo approaches, we help ensure that medical devices, diagnostics, and combination products meet rigorous regulatory standards (FDA, ISO, ASTM) and perform safely and effectively in clinical applications. What sets MED apart is our ability to leverage clinical, scientific, and regulatory expertise during every stage of the pre-clinical evaluation process. This unique combination strengthens the scientific foundation of your study, streamlines the path to regulatory submission, and accelerates the translation of innovative healthcare technologies into the clinic.
OUR COMMITMENT
We are committed to consistently performing services with high quality, that deliver exceptional results, and add value to the client’s business.
For client surveys sent in 2024, we received ratings of 4.98/5 points (13).